Intuitive Surgical, Inc. (0R29.L)
USD 527.02
(-3.15%)
USD 527.02
(-3.15%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.39 Billion USD | 38.77% |
| 2022 | 1.57 Billion USD | -13.39% |
| 2021 | 1.82 Billion USD | 73.46% |
| 2020 | 1.04 Billion USD | -23.62% |
| 2019 | 1.37 Billion USD | 14.6% |
| 2018 | 1.32 Billion USD | 13.73% |
| 2017 | 1.15 Billion USD | 11.57% |
| 2016 | 1.05 Billion USD | 27.73% |
| 2015 | 740 Million USD | 35.83% |
| 2014 | 619.2 Million USD | -36.09% |
| 2013 | 919.8 Million USD | -2.92% |
| 2012 | 935.9 Million USD | 26.38% |
| 2011 | 741.3 Million USD | 25.14% |
| 2010 | 595.6 Million USD | 47.1% |
| 2009 | 377.43 Million USD | 12.36% |
| 2008 | 335.91 Million USD | 52.85% |
| 2007 | 219.76 Million USD | 54.09% |
| 2006 | 107.35 Million USD | 87.62% |
| 2005 | 75.49 Million USD | 170.97% |
| 2004 | 21.18 Million USD | 1805.35% |
| 2003 | -1.25 Million USD | 89.47% |
| 2002 | -15.67 Million USD | 0.55% |
| 2001 | -15.67 Million USD | 9.78% |
| 2000 | -17.52 Million USD | -0.64% |
| 1999 | -17.3 Million USD | 43.76% |
| 1998 | -30.77 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 693.5 Million USD | 2.12% |
| 2024 Q1 | 578.7 Million USD | 4.5% |
| 2024 Q2 | 679.1 Million USD | 17.35% |
| 2023 Q3 | 574.4 Million USD | 24.01% |
| 2023 Q2 | 463.2 Million USD | 19.5% |
| 2023 Q1 | 387.6 Million USD | 4.05% |
| 2023 FY | - USD | 38.77% |
| 2023 Q4 | 573.4 Million USD | -0.17% |
| 2022 Q3 | 398.9 Million USD | 0.33% |
| 2022 Q1 | 408.1 Million USD | -9.39% |
| 2022 FY | - USD | -13.39% |
| 2022 Q4 | 372.5 Million USD | -6.62% |
| 2022 Q2 | 397.6 Million USD | -2.57% |
| 2021 FY | - USD | 73.46% |
| 2021 Q2 | 511.2 Million USD | 22.65% |
| 2021 Q1 | 416.8 Million USD | 0.24% |
| 2021 Q4 | 450.4 Million USD | 1.76% |
| 2021 Q3 | 442.6 Million USD | -13.42% |
| 2020 Q3 | 270.4 Million USD | 235.48% |
| 2020 FY | - USD | -23.62% |
| 2020 Q1 | 283 Million USD | -28.82% |
| 2020 Q2 | 80.6 Million USD | -71.52% |
| 2020 Q4 | 415.8 Million USD | 53.77% |
| 2019 FY | - USD | 14.6% |
| 2019 Q4 | 397.6 Million USD | 8.72% |
| 2019 Q3 | 365.7 Million USD | 1.87% |
| 2019 Q2 | 359 Million USD | 42.35% |
| 2019 Q1 | 252.2 Million USD | -31.52% |
| 2018 Q2 | 306.6 Million USD | 10.81% |
| 2018 Q4 | 368.3 Million USD | 17.56% |
| 2018 FY | - USD | 13.73% |
| 2018 Q1 | 276.7 Million USD | -15.38% |
| 2018 Q3 | 313.3 Million USD | 2.19% |
| 2017 Q2 | 257.5 Million USD | 34.46% |
| 2017 Q1 | 191.5 Million USD | -27.57% |
| 2017 FY | - USD | 11.57% |
| 2017 Q4 | 327 Million USD | 17.37% |
| 2017 Q3 | 278.6 Million USD | 8.19% |
| 2016 Q4 | 264.4 Million USD | 3.12% |
| 2016 Q2 | 245.4 Million USD | 21.25% |
| 2016 Q3 | 256.4 Million USD | 4.48% |
| 2016 FY | - USD | 27.73% |
| 2016 Q1 | 202.4 Million USD | -17.69% |
| 2015 Q1 | 130.4 Million USD | -36.82% |
| 2015 Q2 | 173.8 Million USD | 33.28% |
| 2015 Q3 | 189.9 Million USD | 9.26% |
| 2015 FY | - USD | 35.83% |
| 2015 Q4 | 245.9 Million USD | 29.49% |
| 2014 Q4 | 206.4 Million USD | 29.73% |
| 2014 Q1 | 56.6 Million USD | -72.87% |
| 2014 FY | - USD | -36.09% |
| 2014 Q2 | 143 Million USD | 152.65% |
| 2014 Q3 | 159.1 Million USD | 11.26% |
| 2013 Q4 | 208.6 Million USD | 19.75% |
| 2013 Q2 | 218.5 Million USD | -13.02% |
| 2013 Q1 | 251.2 Million USD | 1.25% |
| 2013 FY | - USD | -2.92% |
| 2013 Q3 | 174.2 Million USD | -20.27% |
| 2012 Q1 | 193.3 Million USD | -8.82% |
| 2012 FY | - USD | 26.38% |
| 2012 Q4 | 248.1 Million USD | 17.36% |
| 2012 Q3 | 211.4 Million USD | -6.17% |
| 2012 Q2 | 225.3 Million USD | 16.55% |
| 2011 Q4 | 212 Million USD | 18.5% |
| 2011 Q3 | 178.9 Million USD | 6.42% |
| 2011 FY | - USD | 25.14% |
| 2011 Q2 | 168.1 Million USD | 13.35% |
| 2011 Q1 | 148.3 Million USD | -9.85% |
| 2010 Q2 | 139.7 Million USD | 7.71% |
| 2010 Q4 | 164.5 Million USD | 24.53% |
| 2010 Q3 | 132.1 Million USD | -5.44% |
| 2010 Q1 | 129.7 Million USD | -5.37% |
| 2010 FY | - USD | 47.1% |
| 2009 Q1 | 53.02 Million USD | -41.24% |
| 2009 FY | - USD | 12.36% |
| 2009 Q4 | 137.06 Million USD | 31.17% |
| 2009 Q3 | 104.49 Million USD | 4.97% |
| 2009 Q2 | 99.54 Million USD | 87.73% |
| 2008 Q4 | 90.24 Million USD | -1.72% |
| 2008 FY | - USD | 52.85% |
| 2008 Q3 | 91.81 Million USD | 8.84% |
| 2008 Q2 | 84.36 Million USD | 21.38% |
| 2008 Q1 | 69.5 Million USD | -9.86% |
| 2007 Q3 | 57.37 Million USD | 19.28% |
| 2007 Q2 | 48.1 Million USD | 29.34% |
| 2007 Q1 | 37.19 Million USD | -41.66% |
| 2007 FY | - USD | 54.09% |
| 2007 Q4 | 77.1 Million USD | 34.38% |
| 2006 Q3 | 28.27 Million USD | 5.93% |
| 2006 FY | - USD | 87.62% |
| 2006 Q2 | 26.69 Million USD | 11.7% |
| 2006 Q1 | 23.9 Million USD | -17.38% |
| 2006 Q4 | 63.74 Million USD | 125.43% |
| 2005 Q2 | 16.01 Million USD | 62.45% |
| 2005 Q3 | 21.21 Million USD | 32.5% |
| 2005 Q4 | 28.92 Million USD | 36.33% |
| 2005 Q1 | 9.85 Million USD | -31.45% |
| 2005 FY | - USD | 170.97% |
| 2004 Q4 | 14.38 Million USD | 120.74% |
| 2004 Q1 | 1.53 Million USD | 11.82% |
| 2004 Q2 | 5.62 Million USD | 266.86% |
| 2004 Q3 | 6.51 Million USD | 15.84% |
| 2004 FY | - USD | 1805.35% |
| 2003 Q2 | 1.86 Million USD | 155.34% |
| 2003 FY | - USD | 89.47% |
| 2003 Q1 | -1.9 Million USD | -633.42% |
| 2003 Q4 | 266 Thousand USD | 176.55% |
| 2003 Q3 | -1.48 Million USD | -217.98% |
| 2002 Q3 | -5.66 Million USD | -66.25% |
| 2002 Q4 | -1.82 Million USD | 93.81% |
| 2002 Q2 | -3.1 Million USD | 34.89% |
| 2002 Q1 | -5.08 Million USD | -420.04% |
| 2002 FY | - USD | 0.55% |
| 2001 Q4 | -3.9 Million USD | 81.25% |
| 2001 Q2 | -3.76 Million USD | -10.88% |
| 2001 Q1 | -4.02 Million USD | 17.92% |
| 2001 FY | - USD | 9.78% |
| 2001 Q3 | -4.68 Million USD | -28.2% |
| 2000 Q4 | -4.9 Million USD | -20.43% |
| 2000 Q3 | -4.07 Million USD | -4.2% |
| 2000 FY | - USD | -0.64% |
| 2000 Q2 | -3.9 Million USD | 15.7% |
| 2000 Q1 | -4.63 Million USD | 0.0% |
| 1999 FY | - USD | 43.76% |
| 1998 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 2425.611% |
| Accuray Incorporated | 9 Million USD | -26474.537% |
| Align Technology, Inc. | 799.03 Million USD | -199.622% |
| Elevance Health Inc. | 10.49 Billion USD | 77.177% |
| AxoGen, Inc. | -13.32 Million USD | 18062.935% |
| Boston Scientific Corporation | 3.61 Billion USD | 33.737% |
| CVS Health Corporation | 18.17 Billion USD | 86.83% |
| Cardinal Health, Inc. | 1.97 Billion USD | -21.036% |
| Centene Corporation | -463 Million USD | 617.084% |
| DaVita Inc. | 2.34 Billion USD | -2.031% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 81.18% |
| Hologic, Inc. | 1.29 Billion USD | -84.701% |
| Humana Inc. | -561 Million USD | 526.756% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | -96.614% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | -77.42% |
| Masimo Corporation | 236.7 Million USD | -911.449% |
| McKesson Corporation | 4.66 Billion USD | 48.702% |
| Patterson Companies, Inc. | 374.75 Million USD | -538.842% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | -38.227% |
| ResMed Inc. | 1.6 Billion USD | -49.6% |
| Henry Schein, Inc. | 943 Million USD | -153.881% |
| Teladoc Health, Inc. | 153.99 Million USD | -1454.641% |
| Universal Health Services, Inc. | 1.74 Billion USD | -37.322% |
| Veeva Systems Inc. | 429.33 Million USD | -457.631% |
| Baxter International Inc. | 2.77 Billion USD | 13.757% |
| Becton, Dickinson and Company | 4.27 Billion USD | 43.998% |
| Danaher Corporation | 7.49 Billion USD | 68.074% |
| Stryker Corporation | 5.16 Billion USD | 53.603% |
| Medtronic plc | 9.05 Billion USD | 73.563% |